Tag
This tweet from Lior discusses agent performance in reinforcement learning with dynamic environments, while highlighting PatronusAI's $50M Series B funding led by GreenfieldVC for developing AI simulations and evaluations.
Warp announces a $60M Series B led by Battery Ventures, totaling $85M in under a year, to build an AI-native employee management platform replacing legacy HCMs.
Fomo announces a $75M Series B funding round led by Index Ventures and USV, with continued support from Benchmark, aiming to bring on excellent partners.
Odyssey, a world model AI startup, raised a $310 million Series B at a $1.45 billion valuation, backed by Amazon, AMD Ventures, GV, and others. The company builds world models for gaming and robotics and will optimize for AWS Trainium chips.
OdysseyML announces a $310M Series B funding round to advance world models, with backing from Natural Capital, Amazon, GV, AMD, and IQT.
OpenRouter, a platform providing unified API access to multiple AI models, has raised $113 million in Series B funding to expand its infrastructure and capabilities.
OpenRouter raised $113 million in Series B funding led by CapitalG, doubling its valuation to $1.3 billion post-money. The AI gateway startup now offers access to over 400 models and processes 25 trillion tokens per week.
Campfire is an AI-native ERP for high-growth tech companies, automating finance and accounting tasks. The company recently raised a Series B and has grown rapidly since launching from a Google Sheet.
RADAR raises $170M Series B at $1B+ valuation to expand its Physical AI platform that provides real-time item-level inventory accuracy for retail stores.
Dust raises $40M Series B led by Abstract and Sequoia to build a 'multiplayer' operating system for enterprise AI, enabling teams to deploy and govern fleets of specialized AI agents that collaborate with humans.
Vapi_ai announces a $50M Series B funding round led by Peak XV Partners, totaling $72M raised, with a focus on engineering for AI voice calls.
Isomorphic Labs, an AI-driven drug discovery company founded by Demis Hassabis, announced a $2.1 billion Series B funding round led by Thrive Capital to scale its business and advance its AI drug design engine, IsoDDE.